Home > Cashflow Statement > CONCORD BIOTECH

CONCORD BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹245 Cr₹265 Cr₹246 Cr₹207 Cr₹167 Cr

What is the latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH ?

The latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH is ₹245 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹245 Cr
Mar2024₹265 Cr
Mar2023₹246 Cr
Mar2022₹207 Cr
Mar2021₹167 Cr

How is Cash Flow from Operating Activities of CONCORD BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹245 Cr
-7.89
Mar2024 ₹265 Cr
7.91
Mar2023 ₹246 Cr
18.57
Mar2022 ₹207 Cr
24.37
Mar2021 ₹167 Cr -

Compare Cash Flow from Operating Activities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹11,939.0 Cr -2.8% -2.2% -30.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-2.8%

-2.2%

-30.2%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses